Arterial distensibility in chronic inflammatory rheumatic disorders

Open Cardiovascular Medicine Journal

Volumn 4, Issue SPEC. ISSUE 1, 2010, Pages 83-88

  Yildiz, Mustafa ^a  

^a Kartal Ko uyolu Yüksek Ihtisas Educational and Research Hospital   (Turkey)

Author keywords

Arterial distensibility; Inflammation; Pulse wave velocity; Rheumatic diseases

Indexed keywords

AORTA ARCH SYNDROME; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; BEHCET DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; FAMILIAL MEDITERRANEAN FEVER; FEMORAL ARTERY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PULSE WAVE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WEGENER GRANULOMATOSIS;

EID: 78249248062     PISSN: None     EISSN: 18741924     Source Type: Journal    
DOI: 10.2174/1874192401004010083     Document Type: Article

References (83)

1. Wållberg-Jonsson S, Johansson H, Ohman ML, Rantapää- Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropozitive rheumatoid arthritis: a retrospective cohort study from disease onset. J Rheumatol 1999; 26: 2562-2571.
2. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-15.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
4. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26: 485-490.
5. Yildiz M. Commentary on viewpoint: the human cutaneous circulation as a model of generalized microvascular function. J Appl Physiol 2008; 105: 382.
6. Moens AI. Die Pulskurve. Leiden, E.J. Brill, 1878; p. 90.
7. Korteweg DJ. Über die Fortpflanzungsgeschwindigkeit des Schalles in elastischen Röhren. Ann Phys Chem Neue Folge 1878; 5: 225.
8. Bramwell JC, Hill AV. The velocity of the pulse wave in man. Proc R Soc Lond (Biol) 1922; 93: 298-306.
9. Wang YX, Fitch RM. Vascular stiffness: measurements, mechanisms and implications. Curr Vasc Pharmacol 2004; 2: 379-384.
10. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
11. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
12. Olivetti G, Anversa P, Melissari M, Loud AV. Morphometry of medial hypertrophy in the rat thoracic aorta. Lab Invest 1980; 42: 559-565.
13. McEniery CM, Wilkinson IB. Large artery stiffness and inflammation. J Hum Hypertens 2005; 19: 507-9.
14. Schiffrin EL. Vascular stiffening and arterial compliance: implications for systolic blood pressure. Am J Hypertens 2004; 17: 39S-48S.
15. Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. Q J Med 2002; 95: 67-74.
16. Learoyd BM, Taylor MG. Alterations with age in the viscoelastic properties of human arterial walls. Circ Res 1966;18: 278-292.
17. Armentano RL, Barra JG, Levenson J, Simon A, Pichel RH. Arterial wall mechanics in conscious dogs: assessment of viscous, intertial, and elastic moduli to characterize aortic wall behavior. Circ Res 1995; 76: 468-478.
18. Korurek M, Yildiz M, Yüksel A. Modeling of the arterial compli- ance in the different stage of primary hypertension using equivalent electronic system. Atherosclerosis (Abst) 2008; 9: S235.
19. Boutouyrie P, Bézie Y, Lacolley P, et al. In vivo/in vitro compari- son of rat abdominal aorta wall viscosity. Influence of endothelial function. Arterioscler Thromb Vasc Biol 1997; 17: 1346-1355.
20. Yildiz M, Akdemir O. Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure. Cardiol Young 2009; 6: 1-6.
21. Yildiz M, Sahin B, Sahin A. Acute effects of oral melatonin administration on arterial distensibility, as determined by carotid-femoral pulse wave velocity, in healthy young men. Exp Clin Cardol 2006; 11: 311-313.
22. Altun A, Erdogan O, Yildiz M. Acute effect of DDD versus VVI pacing on arterial distensibility. Cardiology 2004; 102: 89-92.
23. Hingorani AD, Cross J, Kharbanda RK, et al. Acute systemic in- flammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-9.
24. Kaplan MJ. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol 2009; 5: 208-217.
25. Kaplan MJ. Cardiometabolic risk in psoriasis: differential effects of biologic agents. Vasc Health Risk Manag 2008; 4: 1229-1235.
26. Gasparyan AY, Ugurlucan M. The emerging issue of cardiovascu- lar involvement in familial Mediterranean fever. Arch Med Sci 2008; 4: 465-467.
27. Yildiz M, Soy M, Kurum T, Ozbay G. Increased pulse wave velocity and shortened pulse wave propagation time in young patients with rheumatoid arthritis. Can J Cardiol 2004; 20: 1097-1100.
28. Yildiz M, Yildiz SB, Soy M, Tutkan H. Impairment of arterial distensibility in premenopausal women with systemic lupus erythematosus. Kardiol Pol 2008; 66: 1194-1199.
29. Yildiz M, Soy M, Kürüm T, Yildiz BS. Arterial distensibility in Wegener's granulomatosis: a carotid-femoral pulse wave velocity study. Anadolu Kardiyol Derg 2007; 7: 281-285.
30. Soy M, Yildiz M, Sevki UM, Karaca N, Güfer G, Piskin S. Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse- wave velocity measurement. Rev Esp Cardiol 2009; 62: 96-99.
31. Yildiz M, Masatlioglu S, Seymen P, Aytac E, Sahin B, Seymen HO. The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever. Can J Cardiol 2006; 22: 1127-1131.
32. Yildiz M, Biteker M, Ozkan M. Assessment of aortic stiffness and ventricular functions in familial Mediterranean fever. Anadolu Kardiyol Derg 2008; 8: 395.
33. Balci H, Sipahi DS, Yildiz M, Metin G, Simse KG. The evaluation of the relationship between the inflammatory markers and arterial distensibility in patients with sarcoidosis. Trakya Üniversitesi Ti{dotless}p Fakültesi Dergisi 2010 (in press).
34. Yildiz M, Altun A, Ozbay G. Assessment of arterial distensibility in patients with cardiac syndrome X. Angiology 2007; 58: 458-462.
35. Kurum T, Yildiz M, Soy M, Ozbay G, Alimgil L, Tüzün B. Arterial distensibility as determined by carotid-femoral pulse wave velocity in patients with Behçet's disease. Clin Rheumatol 2005; 24: 134-138.
36. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
37. Wong M, Toh L, Wilson A, et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 2003; 48: 81-89.
38. Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP. Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function. Arthritis Rheum 2003; 48: 72-80.
39. Selzer F, Sutton-Tyrrell K, Fitzgerald S, Tracy R, Kuller L, Manzi S. Vascular stiffness in women with systemic lupus erythematosus. Hypertension 2001; 37: 1075-1082.
40. Hahn BH. Systemic lupus erythematosus and accelerated atherosclerosis. N Engl J Med 2003; 349: 2379-2380.
41. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000; 15: 145-151.
42. Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006; 54: 3918-3925.
43. Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000; 59: 321-325.
44. Tsimakis S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005; 353: 46-57.
45. Wityk RJ, Kittner SJ, Jenner JL, et al. Lipoprotein (a) and the risk of ischemic stroke in young women. Atherosclerosis 2000; 150: 389-396.
46. Henn V, Slupsky JR, Gräfe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Na- ture 1998; 391: 591-594.
47. Lamprecht P, Gross WL. Wegener's granulomatosis. Herz 2004; 29: 47-56.
48. Csernok E, Muller A, Gross WL. Immunopathology of ANCA- associated vasculitis. Intern Med 1999; 38: 759-765.
49. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo.Clin Exp Immunol 1994; 95: 244-250.
50. Jagiello P, Gencik M, Arning L, et al. New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 2004; 114: 468-477.
51. Reumaux D, Duthilleul P, Roos D. Pathogenesis of disease associ- ated with antineutrophil cytoplasmic autoantibodies. Hum Immunol 2004; 65: 1-12.
52. de Leeuw K, Sanders J-S, Stegeman C, Smit A, Kallenberg CG, Bijl M. Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 2005; 64: 753-759.
53. Myers W, Opeola M, Gottlieb AB. Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2004; 6: 306-313.
54. Gaspari AA. Innate and adaptive immunity and the pathophysiol- ogy of psoriasis. J Am Acad Dermatol 2006; 54 (3 Suppl 2): S67-80.
55. Scarpa R, Oriente P, Pucino A, et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 1984: 23: 246-250.
56. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004; 34: 585-592.
57. Gisondi P, Fantin F, Del Giglio M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009; 218: 110-113.
58. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-253.
59. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the familial Mediterranean fever. N Engl J Med 1986; 314: 1001-5.
60. Pras E, Aksentijevich I, Gruberg L, et al. Mapping of a gene caus- ing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 1992; 326: 1509-1513.
61. Ayesh SK, Ferne M, Flechner I, Babior BM, Matzner Y. Partial characterization of a C5a-inhibitor in peritoneal fluid. J Immunol 1990; 144: 3066-3070.
62. Schatner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1991; 90: 434-438.
63. Smith MJ, Ford-Hutchinson AW, Bray MA. Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol 1980; 32: 517-518.
64. Huang ZS, Jeng JS, Wang CH, Yip PK, Wu TH, Lee TK. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 2001; 158: 431-436.
65. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: the atherosclerosis risk in communities (ARIC) Study. Am J Epidemiol 1992; 136: 525-537.
66. Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996; 16: 499-503.
67. Scadding JG, Mitchell DN. Sarcoidosis. 2nd ed. Chapman & Hall: London 1985.
68. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12: 716-738.
69. Takemura T, Shishiba T, Akiyama O, Oritsu M, Matsui Y, Eishi Y. Vascular involvement in cutaneous sarcoidosis. Pathol Int 1997; 47: 84-9.
70. Gran JT. Multiorgan sarcoidosis presenting with symmetric polyarthralgia, cutaneous vasculitis, and sicca symptoms. Scand J Rheumatol 1997; 26: 225-256.
71. Muscari A, Nanni Costa A, Bozzoli C, et al. Immunologic changes in circulating leukocytes in presence of atherosclerotic disease. Recent Prog Med 1994; 85: 66-73.
72. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341: 1284-1291.
73. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto- oxidative damage in Behçet's disease - endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982; 49: 247-255.
74. Freitas JP, Filipe P, Yousefi A, Emerit I, Guerra Rodrigo F. Oxida- tive stress in Adamantiades-Behçet's disease. Dermatology 1998; 197: 343-8.
75. Orem A, Deger O, Cimsit G, Karahan SC, Akyol N, Yildirmis S. Plasma lipoprotein (a) and its relationship with disease activity in patients with Behçet's disease. Eur J Clin Chem Clin Biochem 1995; 33: 473-478.
76. Orem A, Cimsit G, Deger O, Vanizor B, Karahan SC. Autoantibodies against modified low-density lipoprotein in patients with Behçet's disease. Dermatology 1999; 198: 243-246.
77. Chang HK, Kim SK, Lee SS, Rhee MY. Arterial stiffness in Behcet's disease: increased regional pulse wave velocity values. Ann Rheum Dis 2006; 65: 415-416.
78. Medsger TA, Masi AT. Epidemiology of progressive systemic sclerosis. Clin Rheum Dis 1979; 5: 15-25.
79. Timár O, Soltész P, Szamosi S, et al. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheu- matol 2008; 35: 1329-1333.
80. Cypiene A, Laucevicius A, Venalis A, et al. The impact of sys- temic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 2008; 27: 1517-1522.
81. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol 2002; 55: 481-486.
82. Arend WP, Michel BA, Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Takayasu's ar- teritis. Arthritis Rheum 1990; 33: 1129-1134.
83. Ng WF, Fantin F, Ng C, et al. Takayasu's arteritis: a cause of prolonged arterial stiffness. Rheumatology (Oxford) 2006; 45: 741-745.